Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for ex vivo human myocardial ischemia-reperfusion injury
NL-OMON40313Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of eplerenone in myocardial infarction (MI) and myocardial ischemia-reperfusion injury, sponsored by Radboud University Medical Center. Started Mar 2014; status: active, not recruiting.
02
Drugs
eplerenone
03
Conditions
myocardial infarction (MI)myocardial ischemia-reperfusion injury
Beyond the preview
Go deeper on NL-OMON40313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40313.